Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City
COMMITTED2-KC
COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City
1 other identifier
interventional
26
1 country
1
Brief Summary
This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2024
CompletedFirst Posted
Study publicly available on registry
April 18, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 12, 2025
CompletedJanuary 7, 2026
January 1, 2026
1.2 years
April 15, 2024
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time in target blood glucose range per CGM
Percent time with blood glucose between 70 to 180 mg/dL
baseline to 14 weeks
Hemoglobin A1C
laboratory value
baseline to 12 weeks
Secondary Outcomes (5)
Diabetes Quality of Life Brief Inventory
baseline to 12 weeks
Diabetes Distress Scale
Baseline to 12 weeks
PROMIS Medication Adherence Scale
Baseline to 12 weeks
Perceived Dietary Adherence Questionnaire
Baseline to 12 weeks
Motivation and Confidence Ruler
Baseline to 12 weeks
Study Arms (2)
Behavioral Intervention with financial rewards and coaching
EXPERIMENTALIndividuals in the treatment group will receive financial rewards (contingency management) and diabetes coaching (motivational interviewing) in addition to wearing a continuous glucose monitor while receiving their usual diabetes treatment.
Control
ACTIVE COMPARATORIndividuals in the control group will not receive any interventions and will only wear a continuous glucose monitor while receiving their usual diabetes treatment.
Interventions
Participants will receive variable financial incentives based on their engagement with the continuous glucose monitor and meeting diabetes treatment goals. In addition, they will participate in three motivational interviewing sessions focused on their diabetes management. Participants will continue to receive their diabetes treatment as usual.
Participants will only receive a continuous glucose monitor, which they may engage with as desired and no further intervention. Participants in the control group will continue to receive their diabetes treatment as usual.
Eligibility Criteria
You may qualify if:
- Diagnosed with type 2 diabetes
- Age 18 to 65
- Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months
- Most recent hemoglobin A1c result between 8.0 and 11.0
- Currently receiving treatment for diabetes by a licensed healthcare provider.
- Reliable access to a personal smart phone that is compatible with CGM
- English speaking
You may not qualify if:
- Type 1 diabetes
- Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease)
- Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan
- Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study
- Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri - Kansas City School of Medicine
Kansas City, Missouri, 64108, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jared Bruce, PhD
University of Missouri, Kansas City
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Because this is a behavioral intervention, participant blinding is not possible. Randomization will occur after baseline assessment and participants will be instructed to not tell their provider their assigned condition.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2024
First Posted
April 18, 2024
Study Start
May 1, 2024
Primary Completion
July 29, 2025
Study Completion
August 12, 2025
Last Updated
January 7, 2026
Record last verified: 2026-01